After 2.5 days of thought leadership discussions during its 30th Anniversary Annual Forum, executive participants of the HealthCare Executive Group (HCEG) voted on and ranked the 2019 HCEG Top 10 critical challenges, issues and opportunities they expect to face in their organizations in the coming year. Background/MethodologyThe rankings were developed in partnership with Change Healthcare and have been published for the last seven years. Executives from the payer, provider, and technology
Read More
Pharma
GSK Acquires Novartis’ Consumer Healthcare Business for $13B
GlaxoSmithKline (GSK) has reached an agreement to acquire Novartis’ consumer healthcare joint venture for $13 billion. The acquisition will enable GSK’s shareholders to capture the full value of GSK’s Consumer Healthcare growth and is well positioned to deliver sales growth, operating margin improvements and attractive returns.Upon terms of the agreement, India remains a priority market for GSK investment and growth. The Consumer Healthcare business will continue to invest in growth
Read More
Digital Health Could Serve As Valuable Asset for Pharma Industry
Digital health is proving to be a valuable asset for the pharma industry, as it points to a more streamlined and more cost-effective drug development process, according to GlobalData, a leading data and analytics company.Recent years have seen a large increase in investment towards digital health – a multifaceted segment of the industry that can combine software-based therapies into various aspects of the drug development process.Rahael Maladwala, Healthcare Analyst at GlobalData, notes:
Read More
Medisafe Launches Free Med Adherence Grader Tool for Pharma Products
Medisafe, a Boston, MA-based medication adherence platform has announced the launch of Adherence Grader, a free data insights tool for the healthcare community interested in tracking medication adherence.Now available at AdherenceGrader.com, the tool gives pharmaceutical brands, researchers, caregivers, journalists and other interested parties across the healthcare continuum instant access to how well Medisafe users adhere to alternative medication regimens on a relative basis.Adherence Grader
Read More
Novartis Selects Cota Healthcare’s Data Analytics Platform to Develop Therapies for Breast Cancer Patients
Novartis Pharmaceuticals Corporation has signed a multi-year agreement with Cota Healthcare, a data and technology platform for value-based precision medicine to help improve clinical and cost outcomes for breast cancer patients. As part of this multi-year agreement, Novartis will leverage Cota's research-grade, real-world evidence, web-based analysis and visualization tools, and be supported by Cota's medical, data science, and technology experts. Utilizing the real-world evidence and
Read More
Study: Pharma Companies Lose $637B Due to Medication Nonadherence
Pharmaceutical companies forfeit an estimated $637 billion a year to medication nonadherence, according to new research paper released by HealthPrize Technologies. The findings builds upon a research paper originally co-authored by HealthPrize and Capgemini Consulting in 2012. At that time, global revenue losses were being estimated at $564 billion annually. HealthPrize Technologies today announced the publication of an update to a research paper co-authored with Capgemini estimating annual
Read More
OurCrowd Launches Israel’s First $50M Digital Health Fund
OurCrowd, an Jerusalem-based global equity crowdfunding platform for accredited investors has launched Israel's first $50 million fund to invest in digital health startups. The new fund called OurCrowd Qure will focus on digital health startups at seed and series A stages in Israel, the US and the Asia Pacific region. Allen Kamer and Dr. Yossi Bahagon has been appointed to lead the fund.OurCrowd Qure has established a collaboration with Johns Hopkins University to provide validation of value,
Read More
IMS Health, Quintiles to Merge in $9B Deal: 10 Things To Know
Healthcare technology provider IMS Health Holdings announced it will merge with biopharma research contract provider Quintiles Transnational Holding in a deal valued at $9 billion. The merged company will be named Quintiles IMS Holdings, Inc. to become an industry-leading information and technology-enabled healthcare service provider. Here are ten key things to know about the $9B merger: 1.Based on equity market capitalization, the combined company is valued at more than $17.6 billion with an
Read More
Report: Life Sciences M&A and the Rise of Personalized Medicine
As the life sciences (pharmaceuticals, biotechnology and medical sectors) M&A reaches new heights, there seems to be no end in sight for life sciences companies' hunger for acquisitions. 94% of life sciences companies are planning to make an acquisition in the next year, with 91% of US respondents expecting these to be cross-border transactions, according to a global study of 100 senior executives at life sciences companies by global law firm Reed Smith, commissioned by Mergermarket.
The
Read More
